» Articles » PMID: 2865152

Beta-blockers and Sleep: a Controlled Trial

Overview
Specialty Pharmacology
Date 1985 Jan 1
PMID 2865152
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The effects on sleep of four beta-blockers, atenolol, propranolol, metoprolol and pindolol, were studied in a placebo-controlled trial. Drugs were administered in random order to 10 female volunteers who acted as their own controls. Subjects were tested five times, each test period lasting 10 nights (2 baseline, 2 low dose, 4 high dose, and 2 withdrawal). A questionnaire concerning subjective appreciation of the quality of the previous night's sleep was completed each morning. Night recordings of muscle tension, eye movement, heart rate and electroencephalogram were recorded on paper and magnetic tape. Analysis of the subjective questionnaires showed that recollection of dreaming and awakening in the night was increased by the three lipophilic drugs, propranolol, metoprolol, and pindolol. These results confirm reports in the literature but are contrary to those expected from considering the effects of noradrenaline on sleep. Analysis of physiological records confirmed subjects' reports that waking was increased by the lipophilic drugs. Dreaming (rapid eye movement sleep, REM) was reduced, as predicted from knowledge of the effect of noradrenaline on sleep. Increased awakening leads to an increase in remembered dreaming which explains the otherwise paradoxical results. Although atenolol had no effect on subjective measures of sleep this hydrophilic drug also reduced REM frequency, suggesting that either it has some central effect, or that REM reduction is due to a peripheral 'shielding' effect.

Citing Articles

Sleep quality, daytime sleepiness, and risk of falling: results from an exploratory cross-sectional study.

Salis F, Lecca R, Belfiori M, Figorilli M, Casaglia E, Congiu P Eur Geriatr Med. 2024; 16(1):197-204.

PMID: 39508993 DOI: 10.1007/s41999-024-01092-w.


Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder.

Geldenhuys C, van den Heuvel L, Steyn P, Seedat S CNS Drugs. 2022; 36(7):721-737.

PMID: 35688992 DOI: 10.1007/s40263-022-00929-x.


Acute sleep interventions as an avenue for treatment of trauma-associated disorders.

Swift K, Thomas C, Balkin T, Lowery-Gionta E, Matson L J Clin Sleep Med. 2022; 18(9):2291-2312.

PMID: 35678060 PMC: 9435330. DOI: 10.5664/jcsm.10074.


Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study.

Pellitteri G, Pez S, Nilo A, Surcinelli A, Gigli G, Lettieri C Front Neurol. 2022; 13:869677.

PMID: 35645951 PMC: 9136084. DOI: 10.3389/fneur.2022.869677.


Circadian Governance of Cardiac Growth.

Latimer M, Young M Cells. 2022; 11(9).

PMID: 35563800 PMC: 9105147. DOI: 10.3390/cells11091494.


References
1.
Kales A, Soldatos C, Cadieux R, Bixler E, Tan T, Scharf M . Propranolol in the treatment of narcolepsy. Ann Intern Med. 1979; 91(5):741-3. DOI: 10.7326/0003-4819-91-5-741. View

2.
. Atenolol and timolol. N Engl J Med. 1982; 307(21):1343-6. DOI: 10.1056/NEJM198211183072116. View

3.
Oswald I . Sleep studies in clinical pharmacology. Br J Clin Pharmacol. 1980; 10(4):317-26. PMC: 1430087. DOI: 10.1111/j.1365-2125.1980.tb01767.x. View